AusperBio AHB-137 gains breakthrough status in China for CHB
AusperBio Therapeutics and Ausper Biopharma have gained breakthrough therapy designation (BTD) in China for their investigational drug, AHB-137, to treat…
AusperBio Therapeutics and Ausper Biopharma have gained breakthrough therapy designation (BTD) in China for their investigational drug, AHB-137, to treat…
ODAIA, a life sciences predictive analytics and commercial insights provider, has secured an investment of $25m in its Series B…
Verismo Therapeutics has received fast track designation from the US Food and Drug Administration (FDA) for its investigational new drug,…